US 12,274,612 B2
Implantable intraluminal device
Matthew A. Johnson, Bear, DE (US)
Assigned to W. L. Gore & Associates, Inc., Newark, DE (US)
Filed by W. L. Gore & Associates, Inc., Newark, DE (US)
Filed on Nov. 28, 2023, as Appl. No. 18/521,013.
Application 18/521,013 is a continuation of application No. 17/509,672, filed on Oct. 25, 2021, granted, now 11,857,407.
Application 17/509,672 is a continuation of application No. 16/528,069, filed on Jul. 31, 2019, granted, now 11,166,806, issued on Nov. 9, 2021.
Application 16/528,069 is a continuation of application No. 15/879,224, filed on Jan. 24, 2018, granted, now 10,405,966, issued on Sep. 10, 2019.
Application 15/879,224 is a continuation of application No. 14/152,545, filed on Jan. 10, 2014, granted, now 9,907,641, issued on Mar. 6, 2018.
Claims priority of provisional application 61/748,881, filed on Jan. 4, 2013.
Prior Publication US 2024/0099828 A1, Mar. 28, 2024
Int. Cl. A61F 2/07 (2013.01); A61F 2/04 (2013.01); A61F 2/852 (2013.01); A61F 2/88 (2006.01); A61F 2/89 (2013.01)
CPC A61F 2/07 (2013.01) [A61F 2/04 (2013.01); A61F 2002/041 (2013.01); A61F 2002/075 (2013.01); A61F 2/852 (2013.01); A61F 2/88 (2013.01); A61F 2/89 (2013.01); A61F 2240/001 (2013.01); A61F 2250/0065 (2013.01); Y10T 29/49826 (2015.01)] 20 Claims
OG exemplary drawing
 
1. A method of treatment comprising:
delivering a stent graft to a treatment site; and
deploying the stent graft at the treatment site such that a first cylindrical segment and a second, adjacent cylindrical segment of the stent graft are in a nested configuration, and whereby fluid flow is facilitated through a fluid flow channel defined between an unsupported end portion of the first cylindrical segment and a supported end portion of the second, adjacent cylindrical segment, the first cylindrical segment and the second, adjacent cylindrical segment being fixedly attached to each other by an elongate axial reinforcement member.